Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 4:17 pm Purchase | 2023-12-31 | 13G | Omega Therapeutics, Inc. OMGA | HarbourVest Partners L.P. | 3,512,110 6.400% | 865,051 (+32.68%) | Filing History |
| 2023-07-21 08:00 am Purchase | 2023-07-11 | 13G | Evelo Biosciences, Inc. EVLO | HarbourVest Partners L.P. | 1,451,876 8.800% | 1,451,876 (New Position) | Filing History |
| 2023-02-14 06:10 am Unchanged | 2022-12-31 | 13G | Evelo Biosciences, Inc. EVLO | HarbourVest Partners L.P. | 153,175 2.800% | 0 (Unchanged) | Filing History |
| 2023-02-14 06:06 am Purchase | 2022-12-31 | 13G | Axcella Health Inc. AXLA | HarbourVest Partners L.P. | 248,317 8.400% | 73,171 (+41.78%) | Filing History |
| 2022-03-29 06:09 am Purchase | 2022-03-16 | 13G | Axcella Health Inc. AXLA | HarbourVest Partners L.P. | 175,146 8.460% | 62,827 (+55.94%) | Filing History |
| 2022-02-14 07:01 am Purchase | 2021-12-31 | 13G | Omega Therapeutics, Inc. OMGA | HarbourVest Partners L.P. | 2,647,059 5.500% | 2,647,059 (New Position) | Filing History |
| 2021-02-16 08:08 am Purchase | 2020-12-31 | 13G | Axcella Health Inc. AXLA | HarbourVest Partners L.P. | 112,319 7.500% | 63,158 (+128.47%) | Filing History |
| 2021-02-16 08:00 am Purchase | 2020-12-31 | 13G | Kaleido Biosciences, Inc. KLDO | HarbourVest Partners L.P. | 1,833,832 5.100% | 1,833,832 (New Position) | Filing History |
| 2021-02-16 07:59 am Purchase | 2020-12-31 | 13G | Evelo Biosciences, Inc. EVLO | HarbourVest Partners L.P. | 153,175 6.600% | 65,000 (+73.72%) | Filing History |